Results 131 to 140 of about 4,928 (175)

Utility of therapeutic drug monitoring in the treatment of major depressive disorder. [PDF]

Curr Opin Psychiatry
Schoretsanitis G, Paulzen M.
europepmc   +1 more source

Chiral iron porphyrin (+)-D₄-(por)FeCl catalyzes highly enantioselective cyclopropanation of alkenes using <i>in situ</i> generated diazoacetonitrile with up to 35 000 product turnover. [PDF]

Chem Sci
Tan HC, Shing KP, Wang HH, Liu Y, Che CM.   +4 more
europepmc   +1 more source

JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis. [PDF]

Sci Rep
Metral S, Genetet S, Gamain B, Mouro-Chanteloup I.   +3 more
europepmc   +1 more source

TRANYLCYPROMINE CEPHALGIA.

, 1963
A M MANN, W A LAING
openalex   +1 more source

Mesenchymal stromal cells 2.0: thinking outside the box. [PDF]

Front Immunol
Mandl GA, Lahrichi M, Matar P, Abusarah J, Farah R, Bikorimana JP, Cisse A, Rafei M.   +7 more
europepmc   +1 more source

Case Report: Personalizing Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression for a Patient with Complex Medical History. [PDF]

Harv Rev Psychiatry
Schmidt JC, Davis R, Rapp E, Rothman M, Fenstermacher E.   +4 more
europepmc   +1 more source

Depression with risks for spontaneous abortion: a meta-analysis. [PDF]

BMC Psychol
Liu J, Zhao M, Zhuan J, Song Y, Han Z, Zhao Y, Ma H, Yang X.   +7 more
europepmc   +1 more source

Case fatality due to overdosage of a combination of tranylcypromine (Parnate) and imipramine (Tofranil).

, 1961
W Babiak
openalex   +1 more source

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma. [PDF]

Neurooncol Adv
Stitzlein LM, Nam D, Hernandez FA, Patel KH, Poche A, Ma H, Impelman K, Gumin J, Wang H, Wang J, Gadd S, Zaky W, Becher O, Dudley RW, Lang FF, Sareddy GR, Chandra J.   +16 more
europepmc   +1 more source

Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method. [PDF]

BMC Med
Brisnik V, Vukas J, Jung-Sievers C, Lukaschek K, Alexander GC, Thiem U, Thürmann P, Schüle C, Fischer S, Baum E, Drey M, Harder S, Niebling W, Janka U, Krause O, Gensichen J, Dreischulte T, POKAL-Group.   +17 more
europepmc   +1 more source